Quick answer
The pathway has five stages: send records and blood work for preliminary review, attend a consultation and repeat testing in Korea, provide the sample for GMP cell expansion, receive the scheduled intravenous infusions, then follow up on kidney markers at one, three and six months — all with nephrology input.
